"Inspection in a Month": Why Knowing GxP Is Not a Privilege but a Business Survival Issue
Imagine: you are responsible for quality at a pharmaceutical manufacturing site. There are 45 days left until a scheduled FDA inspection. An audit can halt shipments, block entry into a new market, or — in the worst case — lead to a batch recall. At that moment, theory is not enough. You need a clear plan: which documents to pull, how to document deviations, what to show the inspector regarding validation.
Every year, regulators (FDA, EMA, WHO) conduct hundreds of inspections. And every year, the top 5 violations remain unchanged: documentation non-conformances, gaps in risk management, errors in handling electronic records. Knowledge of GxP standards is not about "passing an exam." It is about protecting your product, reputation, and budget.
We have launched the course "GxP Standards: GMP, GDP, GCP (FDA, EMA, WHO, ICH)" on the asibiont.com platform — not just for show, but so you can confidently pass an audit and implement a quality system that meets international requirements.
What Is GxP and Why It Is the "Basics" for Pharma
GxP is a collective term for all "Good Practice" standards. In short: these are rules that ensure a product (drug, medical device, substance) goes through its entire journey — from development to pharmacy — without loss of quality.
The main pillars:
| Standard | Full Name | Key Regulatory Documents |
|---|---|---|
| GMP | Good Manufacturing Practice | FDA 21 CFR Part 210/211, EU GMP, WHO TRS |
| GDP | Good Distribution Practice | EU GDP Guidelines, WHO |
| GCP | Good Clinical Practice | ICH E6, FDA 21 CFR Part 312 |
Each of these blocks requires specific knowledge. For example, GMP requires critical attention to process validation and cleanroom cleanliness; GDP requires cold chain control; GCP requires ethics and patient informed consent. But there are also common cross-cutting themes: documentation management, audits, pharmacovigilance, electronic signatures.
What You Will Learn in the Course
The course is designed to give you not just a list of paragraphs from regulations, but a working toolkit. You will master three key areas.
1. Validation and Documentation
One of the most common reasons for Form 483 (FDA warnings) is poorly prepared validation protocols. You will learn:
- how to build a validation master plan according to FDA and EMA;
- how qualification (DQ/IQ/OQ/PQ) differs from process validation;
- how to prepare documentation so that an inspector finds nothing to criticize.
2. Risk Management According to ICH Q9
The principle of "Quality by Design" (QbD) requires decisions based on risk assessment. In the course, you will learn:
- how to conduct Failure Mode and Effects Analysis (FMEA);
- how to apply formal tools (HACCP, fault tree analysis);
- how to link risk assessment with process change actions.
3. Electronic Records and Signatures (21 CFR Part 11, Annex 11)
Digitalization of pharma is a trend of recent years. But electronic documents must be protected from changes and have an audit trail. You will understand:
- how to set up a document management system to meet FDA requirements;
- what a "closed system" is and how to validate it;
- how to avoid typical mistakes when implementing electronic signatures.
The full course program also includes pharmacovigilance, non-conformance management and CAPA, and preparation for inspections (both internal and regulatory).
Who Will Benefit from This Course
The course is designed for a wide audience, but will be especially useful for:
- Quality professionals (QA/QC) — to systematize knowledge and fill gaps in specific regulatory documents;
- Engineers and technologists — to understand how validation requirements affect production processes;
- Regulatory affairs managers (RA) — to understand requirements when submitting dossiers to new markets;
- Students of pharmaceutical and chemical technology specialties — to gain a competitive advantage in employment.
Even if you already work in pharma, the course will help you look at familiar processes through the lens of international standards. For example, many know what "clean rooms" are, but not everyone can explain the difference between classes A/B/C/D according to EU GMP and ISO 14644.
How Learning Works on asibiont.com
We have abandoned the idea of "record a video and forget it." Our format is text lessons generated by artificial intelligence tailored to each student.
Why It Is Effective
- Personalization to your level. If you are a beginner, the system starts with basics: what is GMP, how to read 21 CFR. If you are an experienced professional, lessons immediately cover complex topics: for example, interpreting validation results for atypical deviations.
- 24/7 access. No need to adjust to webinar schedules. You learn at your own pace: in the morning on the subway or late at night after a shift.
- Simple language. The neural network can explain complex regulatory terms in human words. For example, instead of "process verification," you will see: "checking that the equipment does what is stated in the specification."
- Practical assignments. After each topic, there is an assignment that tests understanding. Not a multiple-choice test, but a real task: "Compile a list of documents for a GMP inspection" or "Assess risk using the FMEA method for a specific process."
Technical Side
You get access to a personal account where your learning program lives. Lessons are loaded as you progress. No PDF files — everything is in a convenient web interface, with keyword search, bookmarks, and notes.
Important: we do not use an AI tutor for chat communication. The neural network is busy with the main task — generating high-quality content adapted to your goals. If you have questions about the material, you can always ask the built-in assistant, which will give a detailed answer based on the course knowledge base.
How to Prepare for an FDA Inspection with the Course
Let's simulate a situation. You are preparing for an audit. What does the course provide?
- Documentation check plan. You know which SOPs (Standard Operating Procedures) should be prioritized. For example, the procedure for managing deviations and CAPA is the top-1 most frequently requested by inspectors.
- Inspection scenario. We analyze typical FDA questions: "Show the validation of the last change," "How did you assess the risk when transferring the process?" "Where is the audit trail for the electronic signature?"
- Self-check checklist. After the course, you can conduct an internal audit and find weak spots before the regulator arrives.
A practical example: a company that implemented ICH Q9 after training reduced non-conformances by 40% within six months. This is not magic — it is a systematic approach to quality.
Start Today
The pharmaceutical industry does not forgive mistakes. Fines for GMP violations can reach millions of dollars, and a product recall damages reputation for years. Investing in knowledge is the only way to stay one step ahead.
The course "GxP Standards: GMP, GDP, GCP (FDA, EMA, WHO, ICH)" on asibiont.com is your chance to gain a systematic understanding of international requirements without leaving work. No fluff, only practice: validation, documentation, risk management, pharmacovigilance, electronic records.
Don't wait for an inspector to point out a problem. Become the specialist who knows the answers before the question is asked.
Comments